Finding atrial fibrillation's metabolic signature for personalized prevention
Part of Heart & circulation clinical trials.
This study looks for unique metabolic patterns in people with atrial fibrillation (an irregular heartbeat). The goal is to develop personalized prevention strategies by comparing these patterns between patients and healthy volunteers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have given written consent to participate
- You are covered by a social security plan
- You are not pregnant (confirmed by test if applicable)
- You do not have an active infection or inflammation of the heart (endocarditis or pericarditis) or had one in the last 3 months
- You do not have an active tumor (benign or malignant), chronic autoimmune or inflammatory disease, or chronic liver disease
- You have not had a heart attack in the last 8 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is following people with atrial fibrillation to learn more about heart health when other conditions like obesity, diabetes, or high blood pressure are present. It could help improve treatments in the future.
This trial tests a new way to map the heart's electrical signals to help doctors better target and treat atrial fibrillation (an irregular heartbeat). If you're having a procedure to treat AF, this study may help improve the success of your treatment.
This trial looks at how the heart's electrical signals work in people with hypertrophic cardiomyopathy (a condition where the heart muscle becomes thickened) who also have atrial fibrillation (a type of irregular heartbeat). The goal is to understand these signals better during a planned ablation procedure, which is a treatment to fix the irregular rhythm.
This trial compares two ways of performing a heart procedure called ablation to treat persistent atrial fibrillation, a type of irregular heartbeat. The goal is to see which method works better and is safer for patients.
This study tests a new approach for people with atrial fibrillation (a type of irregular heartbeat) who are also at high risk for stroke. It combines a procedure to fix the heart's electrical signals with closing off a small pouch in the heart to reduce stroke risk, potentially avoiding long-term blood thinners.
This study tests a new way to measure electrical signals in the heart during a procedure called pulmonary vein isolation, which is used to treat atrial fibrillation (an irregular heartbeat). It aims to improve the accuracy of the treatment, which may help your heart stay in a normal rhythm for longer.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.